@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-V6BKC7N2-Z
  skos:prefLabel "Antithyroid Agents"@en, "Antithyroïdiens"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-RR2P0139-L
  skos:prefLabel "Méthylthiouracile"@fr, "Methylthiouracil"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-KQMJCLR5-6 .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-K9FBN5C5-1
  skos:prefLabel "Vasodilator Agents"@en, "Vasodilatateurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-VPH1KFD5-G
  skos:prefLabel "Propylthiouracil"@en, "Propylthiouracile"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-KQMJCLR5-6 .

jvr:-KQMJCLR5-6
  mesh:allowableQualifier jvr:-G4R176S9-J, jvr:-T9HQD7ST-J, jvr:-D0F21513-5, jvr:-NFTHND7Q-8, jvr:-NKM836P1-M, jvr:-R0ZCQ8X6-J, jvr:-L6C0XPHT-4, jvr:-THHNVC7V-3, jvr:-H7K65Q8S-Z, jvr:-M63HSDM7-1, jvr:-TJHVZCRZ-0, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-XV06LPML-W, jvr:-WK5F724J-1, jvr:-Q3979798-W, jvr:-W6SQV79N-S, jvr:-HQRFT0C6-B, jvr:-R3QWLHRG-V, jvr:-CB30NGKB-3, jvr:-S0CS1X5R-5, jvr:-NHL3D2X0-S, jvr:-FWD2BGQ0-9, jvr:-NB0XHT3S-N, jvr:-BT300B3G-Q ;
  mesh:pharmacologicalAction jvr:-V6BKC7N2-Z, jvr:-K9FBN5C5-1 ;
  dc:modified "2016-06-01"^^xsd:date ;
  skos:narrower jvr:-VPH1KFD5-G, jvr:-RR2P0139-L ;
  dc:established "1966-01-01"^^xsd:date ;
  dc:created "1999-01-01"^^xsd:date ;
  skos:prefLabel "Thiouracil"@en, "Thiouracile"@fr ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D013889> ;
  skos:definition "Occurs in seeds of Brassica and Crucifera species. Thiouracil has been used as antithyroid, coronary vasodilator, and in congestive heart failure although its use has been largely supplanted by other drugs. It is known to cause blood dyscrasias and suspected of terato- and carcinogenesis."@en ;
  skos:altLabel "59X161SCYL"@fr, "59X161SCYL"@en, "141-90-2 (Thiouracil)"@en, "141-90-2 (Thiouracil)"@fr, "4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-"@fr, "4(1H)-Pyrimidinone, 2,3-dihydro-2-thioxo-"@en ;
  skos:broader jvr:-THSBWVLK-0 ;
  a mesh:Descriptor, skos:Concept ;
  skos:inScheme jvr: .

jvr:-THSBWVLK-0
  skos:prefLabel "Uracile"@fr, "Uracil"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-KQMJCLR5-6 .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

